Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 3 | Rare Historical Photos

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

Regeneron is trading at historically low valuations as its Dupixent blockbuster drug could get a 30% increase in TAM if the FDA approves its use in COPD.

MarketBeat · Feb 27, 2025

David Lynch death: What are the symptoms and causes of emphysema?

The biggest risk is smoking

The Independent UK · Jan 17, 2025

UK Using AI To Cut Patient Hospital Visits

The government in the United Kingdom is using artificial intelligence (AI) in the healthcare industry to cut down on hospital visits, having already seen a 40% reduction in the number of COPD patients.

International Business Times · Dec 16, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

First new treatment for asthma and COPD in half a century – new study

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

The Conversation · Nov 29, 2024

New Treatment For Asthma, COPD Flare-Ups: Single Dose Of Existing Antibody Injection May Cut Hospitalizations

A recent trial revealed that a single injection of a monoclonal antibody, benralizumab, could be more effective than standard steroid tablets during asthma or COPD flare-ups.

Medical Daily · Nov 29, 2024

What is benralizumab? Breakthrough asthma drug hailed a 'game-changer'

The injection is the first new treatment for asthma and COPD attacks in 50 years

Evening Standard · Nov 28, 2024

Benralizumab: London scientists create 'game-changing' first treatment for asthma attacks in 50 years

Researchers say injection will be ‘game changing’ for people with the respiratory condition

Evening Standard · Nov 27, 2024

Read news from The Economist, FT, and more,
with one subscription

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world

The Guardian - UK · Nov 27, 2024

First treatment in 50 years for serious asthma attacks is ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.

Evening Standard · Nov 27, 2024

First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells

The Independent UK · Nov 27, 2024

Study Finds Daily Dose Of Vitamin B3 Reduces Inflammation In COPD Patients

The study suggests that taking vitamin B3 could reduce lung inflammatory biomarkers by up to 63%.

Medical Daily · Nov 25, 2024

What is COPD and what are the symptoms?

Every winter, GP surgeries and hospitals see an increase in visits from people with respiratory conditions.

The Independent UK · Nov 20, 2024

Could worsening air quality be triggering more COPD flare-ups?

Chronic Obstructive Pulmonary Disease (COPD) refers to long-term lung disease with symptoms like persistent coughing, wheezing, breathlessness, or tightness in the chest. COPD is linked to smoking, but it is also related to exposure to toxic fumes, dust, and even pollution in the environment. COPD causes the airways to become…

The Times of India · Nov 20, 2024

AI urine analysis predicts infection in lung disease patients a week in advance

The technology could help personalise treatment and prevent hospitalisations, academics said.

Evening Standard · Nov 20, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India · Nov 19, 2024

World COPD Day 204: What you need to know about COPD and the risks

Chronic obstructive pulmonary disease (COPD) remains a significant global health issue, now recognized as the fourth leading cause of death worldwide, responsible for about 3.5 million deaths annually. COPD is a chronic, progressive disease affecting airflow and lung function, often caused by smoking, pollution, and other environmental factors. It primarily…

The Times of India · Nov 19, 2024

World COPD Day: The alarming link between COPD and rising pollution level

COPD is becoming all too common as a progressively desolating lung disease around the world, and the associated connection with increasing air pollution is alarming. One of the leading causes of this deadly lung condition is air pollution itself-a carrier of harmful particulates and gases-presented in vast quantities into the…

Dynamite News · Nov 7, 2024

Delhi Poor Air Quality records spike Asthma and COPD cases: AIIMS

AIIMS has reported a increase in cases related to respiratory issues, particularly asthma and COPD allegedly due to Delhi air pollution. Read further on Dynamite News:

The Guardian - UK · Oct 18, 2024

Pollutionwatch: Study reveals indoor pollution’s impact on people with COPD

Researchers find pollution in inside spaces – mainly from gas cooking – had greatest effect on those with the disease

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily · Sep 27, 2024

Best Nebulizers For Your Respiratory Health: Here's How To Use Them Effectively

Nebulizers are simple devices designed to deliver medications to the lungs directly, making them crucial for treating everything from common colds to more serious conditions like asthma and chronic obstructive pulmonary disease (COPD). In this guide, we explore the various types of nebulizers, their unique benefits, and practical tips for…

The Times of India · Sep 24, 2024

Why there are growing cases of respiratory disease in India

According to the 2017 Global Burden of Diseases Report, India is among the countries with the highest burden of chronic respiratory diseases, accounting for 15.69% of global cases and 30.28% of global deaths from these conditions. It has the highest number of COPD cases, with 55.23 million affected, and the…

The Times of India · Aug 18, 2024

Diagnostic tools to detect respiratory diseases and their effectiveness in improving survival rates

Early detection of respiratory diseases plays a crucial role in improving survival rates and quality of life for patients. By identifying these conditions in their early stages, healthcare providers can implement timely interventions that significantly slow disease progression, reduce complications, and improve overall outcomes. From common conditions like asthma and…

Evening Standard · Aug 7, 2024

What is emphysema? David Lynch reveals he has lung condition

The Twin Peaks creator, 78, says he developed the condition after years of smoking but quit two years ago

The Times of India · May 7, 2024

World Asthma Day: The role of sleep in Asthma management

Bronchial Asthma, the most common cause for swelling in the airways and difficulty in breathing, is a very common lifestyle disease with definitive genetic roots. It is so common that it is estimated that 1 in 10 children or 10% of kids worldwide suffer from it. Even though many of…

The Guardian - UK · Mar 24, 2024

Lung disease patients waiting up to 10 years for diagnosis in poorer areas of England

A better testing regime is required as official figures show deaths from chronic obstructive pulmonary disease is three times higher in deprived parts of the country

The Times of India · Feb 23, 2024

Increasing Pneumonia Risk: Protect your lungs with these simple tips

Winter brings with it not just chilly winds and snowy landscapes, but also the heightened risk of respiratory infections like pneumonia. For individuals already grappling with pre-existing lung conditions such as COPD or asthma, or those with compromised immunity, the threat is even more pronounced. However, by adhering to a…

1 2 3 4 5

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.